77 related articles for article (PubMed ID: 18505127)
1. [Experimental BCSC-1 gene therapy on nasopharyngeal carcinoma mediated by adenovirus].
Zhou YQ; Ju JY; Tian Y; Liu Y; Zhu LP
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2008 Apr; 30(2):208-10. PubMed ID: 18505127
[TBL] [Abstract][Full Text] [Related]
2. [Inhibition of malignant activities of nasopharyngeal carcinoma cell by ectopic expression of BCSC-1 gene].
Chen SL; Zhou YQ; Tian Y; Jü JY; Liu Y; Zhu LP
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2007 Oct; 29(5):612-7. PubMed ID: 18051715
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of malignant activities of nasopharyngeal carcinoma cells with high expression of CD44 by siRNA.
Shi Y; Tian Y; Zhou YQ; Ju JY; Qu L; Chen SL; Xiang ZG; Liu Y; Zhu LP
Oncol Rep; 2007 Aug; 18(2):397-403. PubMed ID: 17611662
[TBL] [Abstract][Full Text] [Related]
4. [Experimental siCD44-targeted therapy of human nasopharyngeal carcinoma mediated by adenovirus].
Jod JY; Shi Y; Zhou YQ; Tian Y; Shen L; Liu Y; Zhu LP
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2007 Oct; 29(5):626-30. PubMed ID: 18051718
[TBL] [Abstract][Full Text] [Related]
5. [Ectopic expression of BCSC-1 gene results in enhancement of adhesion and cell cycling blockade of nasopharyngeal carcinoma CNE-2L2 cell].
Chen SL; Zhou YQ; Tian Y; Ju JY; Liu Y; Zhu LP
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2007 Aug; 29(4):533-7. PubMed ID: 19209800
[TBL] [Abstract][Full Text] [Related]
6. [Treatment of hepatocellular carcinoma with a novel gene-viral therapeutic system CNHK300-murine endostatin].
Li GC; Nie MM; Yang JM; Su CQ; Sun LC; Qian YZ; Sham J; Fang GE; Wu MC; Qian QJ
Zhonghua Yi Xue Za Zhi; 2004 Jun; 84(11):943-8. PubMed ID: 15329284
[TBL] [Abstract][Full Text] [Related]
7. Changing the adenovirus fiber for retaining gene delivery efficacy in the presence of neutralizing antibodies.
Särkioja M; Pesonen S; Raki M; Hakkarainen T; Salo J; Ahonen MT; Kanerva A; Hemminki A
Gene Ther; 2008 Jun; 15(12):921-9. PubMed ID: 18401431
[TBL] [Abstract][Full Text] [Related]
8. [Adenovirus mediated angiostatin gene therapy for ovarian cancer: experiment with nude mice].
Jia CR; Yang SY; Han SY; Sun L
Zhonghua Yi Xue Za Zhi; 2008 Aug; 88(31):2204-8. PubMed ID: 19080673
[TBL] [Abstract][Full Text] [Related]
9. Fiber-knob modifications enhance adenoviral tropism and gene transfer in malignant glioma.
Zheng S; Ulasov IV; Han Y; Tyler MA; Zhu ZB; Lesniak MS
J Gene Med; 2007 Mar; 9(3):151-60. PubMed ID: 17351980
[TBL] [Abstract][Full Text] [Related]
10. Treatment of malignant gliomas with a replicating adenoviral vector expressing herpes simplex virus-thymidine kinase.
Nanda D; Vogels R; Havenga M; Avezaat CJ; Bout A; Smitt PS
Cancer Res; 2001 Dec; 61(24):8743-50. PubMed ID: 11751394
[TBL] [Abstract][Full Text] [Related]
11. Chimeric adenoviral vector Ad5/F35-mediated APE1 siRNA enhances sensitivity of human colorectal cancer cells to radiotherapy in vitro and in vivo.
Xiang DB; Chen ZT; Wang D; Li MX; Xie JY; Zhang YS; Qing Y; Li ZP; Xie J
Cancer Gene Ther; 2008 Oct; 15(10):625-35. PubMed ID: 18535621
[TBL] [Abstract][Full Text] [Related]
12. Adenovirus-mediated soluble FLT-1 gene therapy for ovarian carcinoma.
Mahasreshti PJ; Navarro JG; Kataram M; Wang MH; Carey D; Siegal GP; Barnes MN; Nettelbeck DM; Alvarez RD; Hemminki A; Curiel DT
Clin Cancer Res; 2001 Jul; 7(7):2057-66. PubMed ID: 11448924
[TBL] [Abstract][Full Text] [Related]
13. A survivin-mediated oncolytic adenovirus induces non-apoptotic cell death in lung cancer cells and shows antitumoral potential in vivo.
Li B; Liu X; Fan J; Qi R; Bo L; Gu J; Qian Q; Qian C; Liu X
J Gene Med; 2006 Oct; 8(10):1232-42. PubMed ID: 16900558
[TBL] [Abstract][Full Text] [Related]
14. Variability of adenovirus receptor density influences gene transfer efficiency and therapeutic response in head and neck cancer.
Li D; Duan L; Freimuth P; O'Malley BW
Clin Cancer Res; 1999 Dec; 5(12):4175-81. PubMed ID: 10632357
[TBL] [Abstract][Full Text] [Related]
15. A hepatocellular carcinoma-specific adenovirus variant, CV890, eliminates distant human liver tumors in combination with doxorubicin.
Li Y; Yu DC; Chen Y; Amin P; Zhang H; Nguyen N; Henderson DR
Cancer Res; 2001 Sep; 61(17):6428-36. PubMed ID: 11522637
[TBL] [Abstract][Full Text] [Related]
16. [Experimental studies on inhibition of malignant melanoma growth by gene transfer of adenovirus-mediated averse vascular endothelial growth factor165].
Cui Z; Cen Y; Zhang J
Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi; 2006 May; 20(5):499-503. PubMed ID: 16752833
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of tumor growth in xenografted nude mice with adenovirus-mediated endostatin gene comparison with recombinant endostatin protein.
Liang ZH; Wu PH; Li L; Xue G; Zeng YX; Huang WL
Chin Med J (Engl); 2004 Dec; 117(12):1809-14. PubMed ID: 15603709
[TBL] [Abstract][Full Text] [Related]
18. In vivo adenovirus-mediated p53 tumor suppressor gene therapy for colorectal cancer.
Spitz FR; Nguyen D; Skibber JM; Cusack J; Roth JA; Cristiano RJ
Anticancer Res; 1996; 16(6B):3415-22. PubMed ID: 9042200
[TBL] [Abstract][Full Text] [Related]
19. [Growth inhibition of human nasopharyngeal carcinoma cell CNE-2L2 caused by suppression of 6A8 alpha-mannosidase expression].
Yue W; Shi GX; Bai ZL; Zhu LP
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2001 Oct; 23(5):418-22. PubMed ID: 12905853
[TBL] [Abstract][Full Text] [Related]
20. Suppression of tumor growth using a recombinant adenoviral vector carrying the dominant-negative mutant gene Survivin-D53A in a nude mice model.
Zhu DE; Höti N; Song Z; Jin L; Wu Z; Wu Q; Wu M
Cancer Gene Ther; 2006 Aug; 13(8):762-70. PubMed ID: 16543917
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
